Search

everythinglearnresearchcommunity

for

Search:↓

Early menarche may indicate higher risk of severe hirsutism in PCOS patients.

Digital microscopy can help diagnose hirsutism by measuring hair growth.

Less than 10% of nursing students have PCOS, but many show symptoms and poor health habits, needing more education and yearly check-ups.

Adding a topical agent to IPL improves hair reduction and satisfaction without extra side effects.

The Cyp11a1 gene variation has a weak link to PCOS, but higher di-hydro-testosterone levels are found in PCOS patients.

Adolescent females with PCOS have higher serum cystatin C levels, indicating potential metabolic and cardiovascular issues.

Women with PCOS, especially with hirsutism, should be screened for depression and anxiety.

Hyperprolactinemia should be treated before confirming a PCOS diagnosis.

Women with PCOS have worse physical health but similar mental health compared to those without PCOS.

Ayurvedic Panchakarma therapy, Virechan, can effectively manage PCOS symptoms and improve health markers.

Prolactin levels are higher in women with hirsutism but don't relate to its severity.

Fetal scalp cells have more regenerative genes than adult cells, and decellularized muscle matrix is better for muscle repair than commercial alternatives.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Hyperthyroidism can hide signs of high androgen levels in females.

Exposure to fatty acids significantly increased androgen levels in female dogs, suggesting a link to conditions like insulin resistance and PCOS.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Minoxidil showed a 30% success rate for hair growth in a study, and various skin treatments were effective, but some had limitations or side effects.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.